Business Development, Development and Pharma Companies

Pfizer hires Citi analyst Andrew Baum to manage portfolio strategy, business development

Fierce Pharma

MAY 6, 2024

“Our next question will come from Andrew Baum with Citi.” | Citi analyst Andrew Baum, after covering Pfizer for more than a decade, will join the Big Pharma company as chief strategy and innovation officer. In the role, he'll oversee the drugmaker's portfolio management and business development activities.

Business Development

Business Development Development Pharma Companies

VivoPlex raises funding to develop intra-uterine sensor

pharmaphorum

AUGUST 4, 2020

to develop an intra-uterine sensor system and generate clinical data that could be used for European approval. The Future Fund participated in the second tranche of the fundraising alongside other investors, unlocking matched financing and helping to drive the business forward towards commercialisation.

Development

Development Production Pharma Companies Engineer

COVID-19 and Recession: Identifying Long-Term Growth Opportunities

Roots Analysis

FEBRUARY 27, 2024

This is expected to create immense problems across developing countries with the likely exception of India and China. However, some of the pharma companies fared relatively well. Especially big Pharma players, such as Amgen, Pfizer, and BMS demonstrated high single-digit growth in sales during the recession.

Pharma Companies

Pharma Companies Sales Development Marketing

Leading pharmaceutical solid dose (commercial dose) manufacturing companies in contract marketing

Pharmaceutical Technology

SEPTEMBER 8, 2022

Streamlined development, flexibility in manufacturing, and improved product quality at reduced costs, while gaining access to capabilities and capacity are some of the factors fuelling the pharmaceutical solid dosage contract manufacturing market.

Manufacturing

Manufacturing Marketing Contract Manufacturing Containment

How Are Biopharma Companies Evaluating Partnerships in the Rare Disease Space?

Camargo

SEPTEMBER 23, 2020

Thomas Kassberg, Chief Business Officer, Ultragenyx. Thomas Kassberg, Chief Business Officer, Ultragenyx. I think you really need to get the feedback directly from patients and then incorporate that feedback as you think about how you’re going to develop the product to be successful. Tom Kassberg, Ultragenyx. Dan Curran, Takeda.

Business Development

Business Development Drugs Development Production

Ferrer secures worldwide rights to PSP drug

Drug Discovery World

FEBRUARY 23, 2023

Spanish pharma company Ferrer and Swiss biotech Asceneuron have signed a licensing agreement giving Ferrer the rights to ASN90 in progressive supranuclear palsy (PSP), an orphan, tau-related disease with a high unmet medical need. The disease gets progressively worse, causing severe disability within three to five years of onset.

Drugs

Drugs Licensing Licensing Protein

Top 5 Fastest Growing Pharma and Biotech Companies in 2024

XTalks

MAY 29, 2024

Here, we will deep-dive into the top five fastest growing pharma and biotech companies in 2024, showcasing their innovative strategies and inspiring achievements. Pfizer (Overall Rank 268) Leading the list is one of the most renowned pharma companies in the world: Pfizer. Vertex is growing at a CAGR of 28.97

Medicine

Medicine Marketing FDA Approval Development

Synthetic control arms in clinical trials: Making it happen

pharmaphorum

FEBRUARY 1, 2022

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. His research focuses on the development of big data machine learning for tracking the health of complex systems. But what does it take to implement these innovations?

Clinical Trials

Clinical Trials Clinical Trials Trials Engineer

Seqster launches new cloud version of virtual trial data tool

pharmaphorum

JANUARY 14, 2021

Healthcare technology firm Seqster has introduced a new version of its service that aims to help pharma companies work with patients’ data while on virtual clinical trials. Seqster announced the new version of its platform had been launched on the Microsoft Azure cloud at the annual JP Morgan Healthcare Conference. The new Seqster 7.1

Trials

Trials Clinical Trials Clinical Trials Pharma Companies

Merck confirms $11.5bn Acceleron takeover deal

pharmaphorum

SEPTEMBER 30, 2021

.” It also said that “strategic business development” is a top priority for the company at the moment, reflecting a longstanding concern that it has become over-reliant on Keytruda and needs to diversify.

Sales

Sales Pharma Companies Marketing Business Development

COVID-19 underscores need to boost pharma manufacturing in emerging markets

pharmaphorum

MARCH 22, 2021

For the past year, life science companies around the world worked at breakneck speed to develop and manufacture safe and effective treatments to respond to the COVID-19 pandemic. India and China have seen the emergence of strong, local pharma companies. The right answer requires upfront analysis.

Manufacturing

Manufacturing Marketing Vaccination Vaccine

The new technologies strengthening pharmaceutical supply chains

Pharmaceutical Technology

NOVEMBER 9, 2022

The legacy of this disruption has been a rethink in the way pharma companies do business. The pharma supply chain is emerging strongest and most sustainable where there is a high level of automation and digitalization. Visibility that’s not accessible in real time isn’t really visibility at all.

Big Data

Big Data Manufacturing Packaging Packaging

Partnering to advance digital therapeutics offerings

pharmaphorum

APRIL 25, 2022

Aaron Gani, founder and CEO of BehaVR, and Krys Zaluski, director of business development, digital health at Sumitomo Dainippon Pharma, discuss their groundbreaking partnership to develop and commercialise digital therapeutics (DTx) products. . “Our capabilities are very complimentary.

Behavioural Health

Behavioural Health Production Clinical Trials Clinical Trials

RCPE Awarded Two FDA Contracts for Next-Generation Pharma Technology

The Pharma Data

OCTOBER 30, 2020

With an average of only 5 – 10 projects awarded to EU companies by the FDA each year, this development represents a landmark achievement for RCPE and reflects the potential impact of these projects within the global pharma industry. Website: [link] Facebook: [link] Twitter: [link] YouTube: [link]. # # #.

Engineer

Engineer Manufacturing Production Medicine

Ensuring A Zero-Risk Data Privacy Environment When Capturing Medical Insights

pharmaphorum

DECEMBER 15, 2022

It’s not uncommon to find that two pharma companies of similar size and scope, headquartered in the same country, will have different interpretations of legal and regulatory facets. Business Development Account Manager. What is your corporate compliance policy? All towards the goal of “zero-risk”! Robert Hollands.

Regulation

Regulation Compliance Pharma Companies Business Development

Business Consultants: An Intense Drive to Work Excellence

Delveinsight

SEPTEMBER 8, 2021

In the very beginning, it becomes a necessity for a Business Consultant to have appropriate knowledge about their client’s business. So discovering and learning about the company as a whole becomes essential. Apart from identifying problems, the next step for a business consultant is to develop solutions to problems.

Production

Production Marketing Pharma Companies Development

Increasing patient engagement with UK clinical trials

pharmaphorum

FEBRUARY 11, 2021

Pharma companies face many challenges when involving patients in the design of clinical trials – but doing so can have huge benefits further down the line, improving the sustainability and quality of research. He said that this can be used to shape trials to make them easier for patients, with potential benefits in terms of adherence.

Clinical Trials

Clinical Trials Clinical Trials Trials Clinical Research

The new frontiers of pharmaceutical innovation – according to investors ?

Pharmaceutical Technology

MARCH 20, 2023

Pharma companies and world health stand to benefit from new technologies, but it’s a tough time to be an investor – and an even tougher one for firms seeking investment. From close to zero, central bank interest rates have risen to 3% in the Eurozone, 4% in the UK and nearly 5% in the USA.

Gene Therapy

Gene Therapy Genome Genomics Gene

Using big data to stabilise pharma supply chains in an age of disruption

Pharmaceutical Technology

FEBRUARY 15, 2023

Big data analysis can be enormously powerful in providing insights for business strategy throughout the pharma value chain, including in the acceleration of drug discovery and development, optimization of manufacturing processes, management of supply chains and the creation of innovative sales and marketing strategies.

Big Data

Big Data Manufacturing Production Vaccination

Reliable Experts in Pharmacology Market: Pharma Consultants

Delveinsight

SEPTEMBER 8, 2021

Pharma Consultant. From discovery to development and production of any biological product, aid in decision making is given by Pharma Consultants. Pharma Consultancy Modus Operandi. A pharmaceutical consultant provides companies with expert advice on pharmaceutical development and sales.

Marketing

Marketing Production Sales Life Science

Philips on designing innovation and cultivating partnerships – part two

pharmaphorum

AUGUST 1, 2022

Ties Kroezen, venture leader of Community Life Centers and business development manager for Philips Africa, tells us about the challenges present within the African healthcare system, solutions the company developed to help patients and providers connect, and how pharma can assist with delivering better care to African residents.

Development

Development Pharma Companies Drugs Life Science

Hollywood and the Metaverse’s effect on pharma’s content

pharmaphorum

OCTOBER 3, 2022

Gaurav Kapoor, co-founder and executive vice president of Indegene, tells pharmaphorum how pharma can take lessons from the entertainment industry and prepare for the Metaverse to enhance content engagement. Pharma companies’ customer communication methods require reimagining as technology progresses.

Branding

Branding Doctors Doctor Compliance

Empowering rare disease patient advocacy organisations with data

pharmaphorum

FEBRUARY 11, 2022

One is the platform, which is essentially what our internal solution developers capitalise on, and then we externalise that capability to third-party developers.”. External developers can use Komodo’s platform and build analytics modules to explore other use cases using low code or no-code environments. The business of data.

Life Science

Life Science Engineer Development Big Data

BioSpace Movers & Shakers, Dec. 18

The Pharma Data

DECEMBER 17, 2020

Kurtz brings more than 26 years of experience in global manufacturing, engineering, supply chain, CMC development and program management for drugs and devices at various stages of development. Cadavid will be responsible for the strategy, direction and execution of the company’s clinical development programs.

Development

Development Gene Therapy Engineer Life Science

Patient involvement in trial design: looking to the future

pharmaphorum

MARCH 12, 2021

As moderator Gareth Powell – business development officer, patient engagement and clinical development service project lead at the NIHR – noted, the Institute has seen fantastic feedback from patients on the increased use of virtual engagement over the course of pandemic.

Trials

Trials Research Pharma Companies Clinical Trials

LSX Inv€$tival Showcase round-up

pharmaphorum

NOVEMBER 15, 2022

Smith shared this approach, remarking that 4BIO Capital takes a collaborative approach to invest, working closely with the founders and companies to develop a shared vision for growth. But he noted getting the right people on the right path to success allows companies to create a more impactful story to put to investors.

Life Science

Life Science Pharma Companies Marketing Production

Why pharma isn’t yet achieving digital excellence, and how it can get there

pharmaphorum

MARCH 9, 2021

This includes using its technology as a ‘ digital excellence cloud ’ to harness data, content management, insights and execution while also offering business consulting services to help pharma companies with strategy, processes, and change management.

Sales

Sales Doctors Doctor Marketing

What we’re expecting in 2021, and beyond…

pharmaphorum

JANUARY 26, 2021

Pharma companies will need to continually rethink what works and not be afraid to experiment with solutions they’ve never tried before. This trend can be seen as a net positive, in that it will enable digital therapeutic solution developers to concentrate on building the individual vertical products that will live on these platforms.

Clinical Trials

Clinical Trials Clinical Trials Sales Life Science

Using technology to reassess the clinical trial landscape

pharmaphorum

MAY 30, 2022

Many companies realise traditional clinical trial processes need modification to improve efficiency, and partnerships are forming in distinct ways to evaluate how digital therapeutics, such as VR can enhance trial designs and outcomes. He oversees operations, including business development, sales and marketing, and people.

Clinical Trials

Clinical Trials Clinical Trials Trials Big Data

Where are the hottest drug discovery hubs in the US?

Drug Discovery World

APRIL 27, 2023

Dr Mansley also comments that the multitude of biotech and pharma companies in the Greater Boston region means that people regularly move organisations. She said: “When one of our customers leaves a company and moves to a new one up the street, they often get in touch with us, which helps us grow new business.

Life Science

Life Science Drugs Research Gene Splicing

Africa: Unleashing the potential of the new superpower in clinical trials

Pharmaceutical Technology

MARCH 20, 2023

Africa has considerable advantages and opportunities for trialling investigational medicinal products that, if pharma companies can correctly harness, will turn the continent into a superpower for clinical trials. The average representation of other ethnic groups in the US is very low, with 7.3% being African American, 3.4%

Clinical Trials

Clinical Trials Clinical Trials Trials Clinical Supply Chain

Transitioning Between Academia and Industry: Advice from Leading Scientists That Made the Switch

XTalks

OCTOBER 1, 2020

And although academia and industry have often been pitted against each other in the realm of scientific discovery and development, there may be more similarities and synergies between the two than we may think. WeiQi Lin, MD, PhD, executive vice president of research & development and principal scientist, DURECT Corporation.

Scientist

Scientist In-Vitro Research Life Science